Ileus is fatal for around 10% of sufferers
According to a study published in the Turkish Journal of Surgery, people with ileus are some of the most highly admitted in emergency departments. The same study concludes that ileus is fatal for around 10% of sufferers.
For 90% of ileus sufferers, it can be treated by:
- Bowel rest, or the abstinence from eating or drinking anything
- IV fluid therapy
- Nasogastric decompression
- Surgical procedures to remove the intestinal blockage and any damage to the intestines
Surgery, major weight loss, and taking certain medications can all cause ileus. Roughly 1% of semaglutide users develop these extreme, and sometimes chronic, side effects.
In November 2023, a report to the FDA concluded that ileus was the cause of death for two semaglutide users. Semaglutide is the active ingredient in Ozempic, Wegovy, and Rybelsus, which are medications sold in the USA by Novo Nordisk. Despite the link between semaglutide and these serious conditions, Novo Nordisk failed to properly disclose these risks. Ozempic’s label was only updated to include the risk of ileus in September 2023, despite being FDA-approved since 2017.
If you, or any of your loved ones, experienced ileus after taking Ozempic, Wegovy, or Rybelsus, then you may be eligible for financial compensation.
Our law firm is dedicated to helping you receive fair compensation
With over 30 years of experience in the field of personal injury, a seasoned law firm like ours can help you receive the maximum amount possible. We know that this is a difficult time for you, and we're here to make sure that the legal process is easy and stress-free. After receiving your diagnosis, we urge you to reach out to us with your medical records with a clear diagnosis and any proof you have of taking semaglutide. These documents will let us determine whether or not you are eligible to file a claim against the manufacturer.
